Submission Details
| 510(k) Number | K182337 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 28, 2018 |
| Decision Date | October 04, 2018 |
| Days to Decision | 37 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K182337 is an FDA 510(k) clearance for the HYBRID Guidewire, a Guide, Wire, Catheter, Neurovasculature (Class II — Special Controls, product code MOF), submitted by Balt USA, LLC (Irvine, US). The FDA issued a Cleared decision on October 4, 2018, 37 days after receiving the submission on August 28, 2018. This device falls under the Neurology review panel. Regulated under 21 CFR 870.1330.
| 510(k) Number | K182337 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 28, 2018 |
| Decision Date | October 04, 2018 |
| Days to Decision | 37 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | MOF — Guide, Wire, Catheter, Neurovasculature |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1330 |